Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LRMR | US
0.04
0.89%
Healthcare
Biotechnology
30/06/2024
24/04/2026
4.54
4.50
4.58
4.44
Larimar Therapeutics Inc. a clinical-stage biotechnology company focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601 which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia a rare progressive and fatal genetic disease. The company is headquartered in Bala Cynwyd Pennsylvania.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
34.5%1 month
51.0%3 months
150.9%6 months
120.0%-
-
2.33
0.03
0.02
-4.13
-
-
-65.51M
289.68M
289.68M
-
-
-
-
-37.48
4.63
8.57
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.77
Range1M
1.14
Range3M
3.71
Rel. volume
0.77
Price X volume
4.99M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Greenwich LifeSciences Inc | GLSI | Biotechnology | 24.21 | 318.23M | 2.28% | n/a | 0.00% |
| Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 2.35 | 311.55M | 0.86% | n/a | 42.12% |
| Aclaris Therapeutics Inc | ACRS | Biotechnology | 4.3 | 306.78M | -5.49% | n/a | 2.10% |
| Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 7.92 | 305.67M | -3.65% | n/a | 13.09% |
| Akebia Therapeutics Inc | AKBA | Biotechnology | 1.43 | 300.71M | 0.00% | n/a | -309.96% |
| Verrica Pharmaceuticals Inc | VRCA | Biotechnology | 6.98 | 297.83M | 7.55% | n/a | -348.20% |
| NextCure Inc | NXTC | Biotechnology | 10.52 | 294.31M | -15.16% | n/a | 7.21% |
| Foghorn Therapeutics Inc | FHTX | Biotechnology | 5.31 | 293.80M | 2.31% | n/a | -285.69% |
| SELLAS Life Sciences Group Inc | SLS | Biotechnology | 4.46 | 286.92M | -3.88% | n/a | 23.76% |
| Anavex Life Sciences Corp | AVXL | Biotechnology | 3.34 | 283.22M | 0.91% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.31 | 317.09M | 1.85% | n/a | 174.23% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.99 | 277.39M | -0.99% | 13.23 | 0.00% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.9543 | 262.62M | -0.42% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 18.17 | 202.74M | 2.83% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 11.3 | 181.44M | 2.73% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 36.11 | 103.70M | 0.00% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.11 | 99.53M | 1.16% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.765 | 73.67M | 1.69% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.9 | 70.43M | 6.56% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 21.77 | 33.16M | -2.81% | n/a | 204.46% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.13 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.33 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 150.91 | 72.80 | Riskier |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 289.68M | 3.66B | Emerging |